Skip to content

NOEM NOEM Interest Expense, Nonoperating

Interest Expense, Nonoperating at other companies

CTO
Citius Oncology, Inc.CTOR
$33.03K
Spectral AI, Inc. logo
Spectral AI, Inc.MDAI
$258K+1,190%
XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$154K-29.0%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$153K+11.5%
Dakota Gold logo
Dakota GoldDC
$34.37K
Evommune
 logo
Evommune EVMN
$25.8K-72.9%

Other financials

Income statement

See full
Operating income-$196.7K-15.2%
Net income$309.2K-23.9%
EPS (diluted)-$0.01

Balance sheet

See full
Cash & equivalents$26.1K-95.9%
Total debt$11.7K
Total equity-$2.0M-33.3%
Total assets$72.1M+1.7%

Cash flow

See full
Operating cash flow-$1.1M-237%

Valuation

See full
Market cap$100.08M+3.5%
P/E64.4×-47.0×

Returns & leverage

See full
Return on equity-90.8%
Current ratio2.6×+0.7×

Where this comes from

Reported directly by NOEM in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: NOEM’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about NOEM's interest expense, nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NOEM's interest expense, nonoperating?
NOEM (NOEM) reported interest expense, nonoperating of $0 in Q4 2025.
How has NOEM's interest expense, nonoperating changed year-over-year?
NOEM's interest expense, nonoperating decreased by 100.0% year-over-year, from $271.75 to $0.
What does interest expense, nonoperating mean?
Reflects the costs associated with debt financing that are not directly related to core business operations. Monitoring this helps investors understand the company's leverage and the impact of interest obligations on overall financial health.